Occasionally we see it claimed that ME/CFS patients have higher rates of allergy. Sometimes this is mentioned in support of MCAS, but I'm setting that aside for a moment and just looking for what research exists on the allergy claim itself.
So far the results look mixed and confusing. Some...
Efficacy and safety of rivaroxaban, colchicine, and famotidine–loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial (STIMULATE-ICP consortium)
Abstract:
Background
Post-acute...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.